bioprosthesis


Also found in: Dictionary.

bioprosthesis

 [bi″o-pros-the´sis]
a prosthesis made of biological material.

bioprosthesis

/bio·pros·the·sis/ (-pros-the´sis) a prosthesis that contains biological material.bioprosthet´ic

bioprosthesis

Any implanted device of natural (i.e., nonsynthetic) origin designed to replace a defective body part—e.g., a porcine heart valve.

bioprosthesis

An implanted device of natural–ie, nonsynthetic origin–eg, porcine tissue designed to replace a defective body part–eg, a heart valve. See Heart-valve prosthesis.
References in periodicals archive ?
The ProCol[R] Vascular Bioprosthesis uses a mesenteric bovine vein for patients with failed AVGs who require a new access.
My goal is to help deliver a pipeline of innovative bioprosthesis systems in a more rapid fashion.
Thirty-day results of the SAPIEN aortic bioprosthesis European outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN Valve.
A Novel Approach to Tricuspid Valve Replacement: The Upside Down Stentless Aortic Bioprosthesis.
The aortic valve was replaced with a 25 mm Mosaic bioprosthesis.
The explanted device was a conduit with a Carpentier-Edwards porcine bioprosthesis that had been in place for 12 years.
Based on the precept that CyForm Follows Function,' the ATS 3f Aortic Bioprosthesis is a revolutionary next generation stentless pericardial aortic tissue valve that is unlike any other replacement valve, the company said.
The Veterans Affairs Cooperative Study on Valvular Heart Disease: a comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis.
The goal would be to delay the need for aortic valve surgery, or in patients with an existing bioprosthesis, to delay the need for a redo procedure.
has received Communaute Europeenne (CE) Mark approval for its next-generation stentless tissue valve, the Toronto Root bioprosthesis, and will begin a limited European market launch.
Noncompliance with long-term anticoagulation (Bradley, Midgley, Watson, Getson, & Scott, 1985) and high rate of degeneration of bioprosthesis due to calcium deposit (Sanders, Levy, Freed, Norwood, & Castaneda, 1980) have been identified as the two primary factors responsible for inadequate anticoagulation resulting in thromboembolic complications in children with prosthetic cardiac valves